---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-047590"
form_type: "8-K"
ticker: "PRME"
cik: "0001894562"
company_name: "Prime Medicine, Inc."
filed_at: "2026-07-08T12:02:02+00:00"
generated_at: "2026-07-08T12:05:10.332891+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Prime Medicine wins arbitration against Beam; PM647 for AATD confirmed within Prime's field

## Summary
- Arbitration tribunal ruled PM647 (AATD candidate) is within Prime's 'Field' under 2019 Collaboration Agreement with Beam.
- Tribunal denied Beam's claims for damages and injunctive relief; Prime did not breach agreement.
- Remaining claims from both parties were denied.
- This removes legal overhang on Prime's AATD program.

## SEC filing metadata
- accession: 0001628280-26-047590
- form_type: 8-K
- ticker: PRME
- cik: 0001894562
- company_name: Prime Medicine, Inc.
- filed_at: 2026-07-08T12:02:02+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894562/000162828026047590/0001628280-26-047590-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894562/000162828026047590/prme-20260706.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-047590
- JSON: https://secwatch.observer/filing/0001628280-26-047590.json
- Plain text: https://secwatch.observer/filing/0001628280-26-047590.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.